Palomino Laboratories (PALX) EPS (Basic) (2023 - 2025)
Palomino Laboratories (PALX) posted EPS (Basic) of -$0.47 for Q3 2025, down 5320.4% sequentially from -$0.01 in Q2 2025, and down 212134.47% YoY from N/an in Q3 2024.
Palomino Laboratories (PALX) EPS (Basic) (2023 - 2025) Analysis & Trends
Palomino Laboratories has reported EPS (Basic) for 3 years, with the latest figure at -$0.47 in Q3 2025.
- Quarterly EPS (Basic) fell 212134.47% year-over-year to -$0.47 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$0.25 (down 395.57% YoY) and the FY2024 annual result came in at -$0.03, down 22.73% from the prior year.
- EPS (Basic) declined to -$0.47 in Q3 2025 per PALX's latest filing, from -$0.01 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.0 in Q3 2024 and troughed at -$0.47 in Q3 2025.
- A 3-year average of -$0.06 and a median of -$0.01 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 97.39% in 2024, then sank 212134.47% in 2025.
- Over 3 years, EPS (Basic) stood at -$0.01 in 2023, then plunged by 102.91% to -$0.03 in 2024, then plunged by 1632.74% to -$0.47 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.47, -$0.01, and -$0.01 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.47 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |